Your browser doesn't support javascript.
loading
Preparation of PCL Electrospun Fibers Loaded with Cisplatin and Their Potential Application for the Treatment of Prostate Cancer.
Mills, Hilla; Acquah, Ronald; Tang, Nova; Cheung, Luke; Klenk, Susanne; Glassen, Ronald; Pirson, Magali; Albert, Alain; Hoang, Duong Trinh; Van, Thang Nguyen.
Affiliation
  • Mills H; Department of Medical Science, University for Development, Accra, Ghana.
  • Acquah R; Department of Medical Science, University for Development, Accra, Ghana.
  • Tang N; RD Lab, The Hospital Institute for Hebal Research, 50200 Toluca, Mexico, Mexico.
  • Cheung L; RD Lab, The Hospital Institute for Hebal Research, 50200 Toluca, Mexico, Mexico.
  • Klenk S; Research Institution of Clinical Biomedicine, Hospital University Medical Centre, 89000 Ulm, Germany.
  • Glassen R; Research Institution of Clinical Biomedicine, Hospital University Medical Centre, 89000 Ulm, Germany.
  • Pirson M; Industrial Research Group, International College of Science and Technology, Route de Lennik 800, CP 590, 1070 Brussels, Belgium.
  • Albert A; Industrial Research Group, International College of Science and Technology, Route de Lennik 800, CP 590, 1070 Brussels, Belgium.
  • Hoang DT; Clinical Analysis Lab, Center of Bio-Medicine, Hanoi, Vietnam.
  • Van TN; Clinical Analysis Lab, Center of Bio-Medicine, Hanoi, Vietnam.
Emerg Med Int ; 2022: 6449607, 2022.
Article in En | MEDLINE | ID: mdl-35875248
Prostate cancer is a global fatal type of cancer. It is a type of cancer that affect men. Signs and symptoms of the disease include blood in the urine, pain when one micturates, and difficulties in penis erection. Cisplatin chemotherapy is a principal treatment normally given to the prostate cancer patients. Nonetheless, on its own, cisplatin loses efficacy once administered due to liver pass effects and other biochemical attacks. In this paper, we looked at preparation of PCL nanoparticles loaded with cisplatin and their potential for the treatment of prostate cancer. PCL nanoparticles protect cisplatin from biochemical attack, thus increasing drug efficacy. Incorporation of P-glycoprotein inhibitors in PCL nanoparticles (NPs) loaded with cisplatin could improve prostate cancer treatment even more.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Emerg Med Int Year: 2022 Document type: Article Affiliation country: Ghana Country of publication: Egypt

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Emerg Med Int Year: 2022 Document type: Article Affiliation country: Ghana Country of publication: Egypt